Background and Objective: Contraceptive pills are chemical substances used as a means to prevent pregnancy, but they have several
effects, including high lipid profile and in many cases, patients with heart and blood diseases cannot use it as a contraceptive helps in
increasing the risk of cardiovascular diseases (CVD). A Stevia extract with high sweetening capacity due to its content of glycosides is
used to reduce lipid profile and this study aimed to decrease lipid profile levels and lowering the risk factor in women using contraceptive
drugs by stevia extracts. Materials and Methods: Sixteen rabbits have been used as a case-control study design due to their
anatomical and physiological similarity to humans. The stevia leaves are extracted using Soxhlet apparatus of ethanol solvent. Statistical
package (SPSS), were used for data analysis and management using independent sample t-test, test, comparison of means for lipid
profile of Triglyceride (TG), Cholesterol, High-density lipoprotein (HDL-C), Low-density lipoprotein (LDL-C) between (di-contraceptive,
mono-contraceptive and control groups). Results: The results showed increasing cholesterol and LDL-C during the combined oral
contraceptive (COCP) and progesterone-only pills with decreased HDL-C level. A comparison of means before and after stevia used
explains the elevated HDL-C and decreased LDL-C. Conclusion: The lipid profile levels should continuously be monitored during oral
contraceptive intake and Stevia leaf powder extraction is suggested to reduce the risk of CVD.